Yasmin Drug Injury

Posted on | January 16, 2010 | No Comments

Yasmin is an oral contraceptive first made by Berlex Laboratories, which was taken over by Bayer Pharmaceuticals in 2006.  Is contains a progestin called drospirenone, which can cause raised potassium levels.  This condition is called hyperkalemia.   This can lead to deep vein thrombosis (DVT) and pulmonary embolism (PE) as well as strokes and heart attacks.

Bayer’s failure to adequately warn women of these possible serious Yasmin side effects is the root of new Yasmin drug injury lawsuits popping up in state after state across the country.   Current packages of Yasmin do have a warning for hyperkalemia, or raised potassium levels.  However, this does nothing to warn women against thromboembolism, stroke, heart attacks and gall bladder disease.

Bayer also overstated the effectiveness in their Yasmin advertising campaigns, in regards to curing acne and PMS.  Yasmin can relieve these symptoms, but cannot cure them.  But the Yasmin drug injury we’re most concerned with is serious health issues resulting from taking Yasmin.

Simply put, Bayer does not warn women that taking Yasmin can lead to stroke, heart attack, and gall bladder disease.  Warning on packaging are not adequate.  Bayer has been accused of  fraud, civil conspiracy and commercial bribery in the latest Yasmin lawsuits.

Comments